1-20 of 32
Andrew J. Wilson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4973: Investigating the role of non-canonical NF-kappaB signaling in tumor cells and macrophages in ovarian cancer

Andrew J. Wilson, Dominique Parker, Robert Cheng, Todd Giorgio, Marta Crispens, Fiona Yull
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4973.
https://doi.org/10.1158/1538-7445.AM2023-4973
Published: 04 April 2023
View article titled, Abstract 4973: Investigating the role of non-canonical NF-kappaB signaling in tumor cells and macrophages in ovarian cancer
Journal Articles

Abstract 3228: Body mass index and ovarian cancer: Changes after diagnosis and associations with overall survival

Alicia Beeghly-Fadiel, Sharon Phillips, George Bukenya, Pranoti Pradhan, Sara Duque, Nneka Anyanwu, Deok-Soo Son, Andrew J. Wilson, Demetra H. Hufnagel, Marta A. Crispens
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3228.
https://doi.org/10.1158/1538-7445.AM2022-3228
Published: 15 June 2022
View article titled, Abstract 3228: Body mass index and ovarian cancer: Changes after diagnosis and associations with overall survival
Journal Articles

Abstract 5788: Area deprivation index and ovarian cancer survival: Preliminary findings for two validated measures

Demetra H. Hufnagel, Andrew J. Wilson, Fiona E. Yull, Pamela C. Hull, Joellen Schildkraut, Marta A. Crispens, Alicia Beeghly-Fadiel
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 5788.
https://doi.org/10.1158/1538-7445.AM2020-5788
Published: 15 August 2020
View article titled, Abstract 5788: Area deprivation index and ovarian cancer survival: Preliminary findings for two validated measures
Journal Articles

Abstract 1573: Non-canonical NF-kappaB signaling in the tumor microenvironment in relation to ovarian cancer survival

Demetra Hufnagel, Andrew J. Wilson, Jamie Saxon, Timothy Blackwell, Dineo Khabele, Marta A. Crispens, Alicia Beeghly-Fadiel, Fiona Yull
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1573.
https://doi.org/10.1158/1538-7445.AM2019-1573
Published: 01 July 2019
View article titled, Abstract 1573: Non-canonical NF-kappaB signaling in the tumor microenvironment in relation to ovarian cancer survival
Journal Articles

Abstract 3501: Entinostat enhances the efficacy of olaparib in preclinical models of ovarian cancer

Vijayalaxmi G. Gupta, Yoskaly Lazo Fernandez, Katherine Roby, Harsh Pathak, Jeff Hirst, Andrew J. Wilson, Andrew Godwin, Dineo Khabele
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3501.
https://doi.org/10.1158/1538-7445.AM2019-3501
Published: 01 July 2019
View article titled, Abstract 3501: Entinostat enhances the efficacy of olaparib in preclinical models of ovarian cancer
Journal Articles

Abstract 626: Bromodomain inhibition in ovarian cancer and the tumor microenvironment to improve PARP inhibitor response

Andrew J. Wilson, Alyssa Hoover, Whitney Harris, Esther Liu, Dineo Khabele, Fiona Yull
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 626.
https://doi.org/10.1158/1538-7445.AM2018-626
Published: 01 July 2018
View article titled, Abstract 626: Bromodomain inhibition in ovarian cancer and the tumor microenvironment to improve PARP inhibitor response
Journal Articles

Abstract 4711: Modulation of NFκ-B signaling to optimize antitumor characteristics in macrophages

Esther Liu, Alyssa A. Hoover, Whitney R. Harris, Whitney Barham, Oleg Tikhomirov, Dineo Khabele, Zahra Mirafzahli, Todd D. Giorgio, Andrew J. Wilson, Fiona E. Yull
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4711.
https://doi.org/10.1158/1538-7445.AM2018-4711
Published: 01 July 2018
View article titled, Abstract 4711: Modulation of NFκ-B signaling to optimize antitumor characteristics in macrophages
Journal Articles

Abstract 5056: The bromodomain inhibitor JQ1 sensitizes homologous recombination proficient ovarian cancer cells to the PARP inhibitor olaparib

Andrew J. Wilson, Janese Thompson, Abdirahman Osman, Jeanette Saskowski, Dineo Khabele
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5056.
https://doi.org/10.1158/1538-7445.AM2017-5056
Published: 01 July 2017
View article titled, Abstract 5056: The bromodomain inhibitor JQ1 sensitizes homologous recombination proficient ovarian cancer cells to the PARP inhibitor olaparib
Journal Articles

Abstract 4730: The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly ADP-ribose polymerase inhibitor olaparib

Kofi Sarfo-Kantanka, Andrew J. Wilson, Alexandra Steck, Jeanette Saskowski, Dineo Khabele
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4730.
https://doi.org/10.1158/1538-7445.AM2016-4730
Published: 15 July 2016
View article titled, Abstract 4730: The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly ADP-ribose polymerase inhibitor olaparib
Journal Articles

Abstract B37: The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly ADP ribose polymerase inhibitors via E2F1 downregulation.

Andrew J. Wilson, Jeanette Saskowski, Dineo Khabele
Journal: Cancer Research
Cancer Res (2016) 76 (2_Supplement): B37.
https://doi.org/10.1158/1538-7445.CHROMEPI15-B37
Published: 14 January 2016
View article titled, Abstract B37: The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly ADP ribose polymerase inhibitors via E2F1 downregulation.
Journal Articles

Abstract 2068: Cyclooxygenase-1 gene expression contributes to multiple oncogenic pathways in high grade serous ovarian cancer

Andrew J. Wilson, Brian D. Lehmann, Jeanette Saskowski, MD Jashim Uddin, Cristina Daniel, Brenda C. Crews, Qi Liu, Shilin Zhao, Deok-Soo Son, Jennifer A. Pietenpol, Lawrence J. Marnett, Dineo Khabele
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2068.
https://doi.org/10.1158/1538-7445.AM2015-2068
Published: 01 August 2015
View article titled, Abstract 2068: Cyclooxygenase-1 gene expression contributes to multiple oncogenic pathways in high grade serous ovarian cancer
Journal Articles

KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine

Michelle L. Stewart, Pablo Tamayo, Andrew J. Wilson, Stephanie Wang, Yun Min Chang, Jong W. Kim, Dineo Khabele, Alykhan F. Shamji, Stuart L. Schreiber
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (14): 2897–2906.
https://doi.org/10.1158/0008-5472.CAN-14-2860
Published: 14 July 2015
View article titled, <em>KRAS</em> Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine
Open the PDF for <em>KRAS</em> Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine in another window
Includes: Supplementary data
Journal Articles

Abstract 4928: Cyclooxygenase-1 as a target for molecular imaging of high grade serous ovarian cancer

Andrew J. Wilson, Brian D. Lehmann, MD Jashim Ussin, Anna Elleman, Brenda Crews, Jeanette Saskowski, Jennifer Pietenpol, Lawrence J. Marnett, Dineo Khabele
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4928.
https://doi.org/10.1158/1538-7445.AM2014-4928
Published: 01 October 2014
View article titled, Abstract 4928: Cyclooxygenase-1 as a target for molecular imaging of high grade serous ovarian cancer
Journal Articles

TR3 Modulates Platinum Resistance in Ovarian Cancer

Andrew J. Wilson, Annie Y. Liu, Joseph Roland, Oluwafunmilayo B. Adebayo, Sarah A. Fletcher, James C. Slaughter, Jeanette Saskowski, Marta A. Crispens, Howard W. Jones, III, Samuel James, Oluwole Fadare, Dineo Khabele
Journal: Cancer Research
Cancer Res (2013) 73 (15): 4758–4769.
https://doi.org/10.1158/0008-5472.CAN-12-4560
Published: 31 July 2013
View article titled, TR3 Modulates Platinum Resistance in Ovarian Cancer
Open the PDF for TR3 Modulates Platinum Resistance in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 4954: Opposing effects of the NF-kappaB inhibitor thymoquinone in a syngeneic mouse model of ovarian cancer.

Andrew J. Wilson, Jeanette Saskowski, Whitney Barham, Lianyi Chen, Dineo Khabele, Fiona Yull
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4954.
https://doi.org/10.1158/1538-7445.AM2013-4954
Published: 15 April 2013
View article titled, Abstract 4954: Opposing effects of the NF-kappaB inhibitor thymoquinone in a syngeneic mouse model of ovarian cancer.
Journal Articles

Abstract 320: Investigating the patterns of nuclear factor-kappa B activity in the host-tumor microenvironment during ovarian cancer progression

Andrew J. Wilson, Hye-Jeong Lee, Whitney Barham, Lianyi Chen, Halina Onishko, Dineo Khabele, Fiona Yull
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 320.
https://doi.org/10.1158/1538-7445.AM2012-320
Published: 15 April 2012
View article titled, Abstract 320: Investigating the patterns of nuclear factor-kappa B activity in the host-tumor microenvironment during ovarian cancer progression
Journal Articles

Abstract 5291: A preclinical model for investigation of nuclear factor-kappa B inhibitors in ovarian cancer

Andrew J. Wilson, Hye-Jeong Lee, Halina Oshinko, Fiona Yull, Dineo Khabele
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5291.
https://doi.org/10.1158/1538-7445.AM2011-5291
Published: 15 April 2011
View article titled, Abstract 5291: A preclinical model for investigation of nuclear factor-kappa B inhibitors in ovarian cancer
Journal Articles

Abstract 5756: The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis

Higinio Dopeso, Silvia Mateo-Lozano, Veronica Davalos, Rocco Mazzolini, Paulo Rodrigues, Laura Lagares-Tena, Julian Ceron, Jordi Romero, Felip Vilardell, Stefania Landolfi, Javier Hernández-Losa, Andrew J. Wilson, Santiago Ramon y Cajal, Gabriel Capella, Lauri A. Aaltonen, John M. Mariadason, Simo Schwartz Jr, Arango Diego
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5756.
https://doi.org/10.1158/1538-7445.AM10-5756
Published: 15 April 2010
View article titled, Abstract 5756: The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis
Journal Articles

Abstract 2985: DNA-damage related histone marks can distinguish the anti-tumor effects of established and novel histone deacetylase inhibitors in ovarian cancer cells

Andrew J. Wilson, Ed Holson, Srividya Bhaskara, Jahred Carlise, Stuart L. Schreiber, Scott W. Hiebert, Dineo Khabele
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2985.
https://doi.org/10.1158/1538-7445.AM10-2985
Published: 15 April 2010
View article titled, Abstract 2985: DNA-damage related histone marks can distinguish the anti-tumor effects of established and novel histone deacetylase inhibitors in ovarian cancer cells
Journal Articles

Apoptotic Sensitivity of Colon Cancer Cells to Histone Deacetylase Inhibitors Is Mediated by an Sp1/Sp3-Activated Transcriptional Program Involving Immediate-Early Gene Induction

Andrew J. Wilson, Anderly C. Chueh, Lars Tögel, Georgia A. Corner, Naseem Ahmed, Sanjay Goel, Do-Sun Byun, Shannon Nasser, Michele A. Houston, Minaxi Jhawer, Helena J.M. Smartt, Lucas B. Murray, Courtney Nicholas, Barbara G. Heerdt, Diego Arango, Leonard H. Augenlicht, John M. Mariadason
Journal: Cancer Research
Cancer Res (2010) 70 (2): 609–620.
https://doi.org/10.1158/0008-5472.CAN-09-2327
Published: 13 January 2010
View article titled, Apoptotic Sensitivity of Colon Cancer Cells to Histone Deacetylase Inhibitors Is Mediated by an Sp1/Sp3-Activated Transcriptional Program Involving Immediate-Early Gene Induction
Open the PDF for Apoptotic Sensitivity of Colon Cancer Cells to Histone Deacetylase Inhibitors Is Mediated by an Sp1/Sp3-Activated Transcriptional Program Involving Immediate-Early Gene Induction in another window
Includes: Supplementary data